Patients with diabetes who use metformin for at least 5 consecutive years are less likely to develop AMD, particularly the ...

Early device failures, prior authorizations, and not receiving 90-days’ worth of supplies contribute to the problem.

The experimental cholesterol drug obicetrapib slowed Alzheimer’s biomarkers, over 12 months in patients with cardiovascular ...

The studies reviewed were small and heterogeneous and it is unclear which interventions were the most successful.